Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Design and application of diimine-based copper(i) complexes in photoredox catalysis.

Földesi T, Sipos G, Adamik R, Nagy B, Tóth BL, Bényei A, Szekeres KJ, Láng GG, Demeter A, Peelen TJ, Novák Z.

Org Biomol Chem. 2019 Sep 28;17(36):8343-8347. doi: 10.1039/c9ob01331h. Epub 2019 Jul 3.

PMID:
31268086
2.

Platinum Nanoparticle Inclusion into a Carbonized Polymer of Intrinsic Microporosity: Electrochemical Characteristics of a Catalyst for Electroless Hydrogen Peroxide Production.

Adamik RK, Hernández-Ibáñez N, Iniesta J, Edwards JK, Howe AGR, Armstrong RD, Taylor SH, Roldan A, Rong Y, Malpass-Evans R, Carta M, McKeown NB, He D, Marken F.

Nanomaterials (Basel). 2018 Jul 18;8(7). pii: E542. doi: 10.3390/nano8070542.

3.

Interaction of FK506-binding protein 13 with brefeldin A-inhibited guanine nucleotide-exchange protein 1 (BIG1): effects of FK506.

Padilla PI, Chang MJ, Pacheco-Rodriguez G, Adamik R, Moss J, Vaughan M.

Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2322-7. Epub 2003 Feb 26.

4.

Protein kinase A-anchoring (AKAP) domains in brefeldin A-inhibited guanine nucleotide-exchange protein 2 (BIG2).

Li H, Adamik R, Pacheco-Rodriguez G, Moss J, Vaughan M.

Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1627-32. Epub 2003 Feb 5.

5.

Identification and localization of two brefeldin A-inhibited guanine nucleotide-exchange proteins for ADP-ribosylation factors in a macromolecular complex.

Yamaji R, Adamik R, Takeda K, Togawa A, Pacheco-Rodriguez G, Ferrans VJ, Moss J, Vaughan M.

Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2567-72.

6.

Similarities in function and gene structure of cytohesin-4 and cytohesin-1, guanine nucleotide-exchange proteins for ADP-ribosylation factors.

Ogasawara M, Kim SC, Adamik R, Togawa A, Ferrans VJ, Takeda K, Kirby M, Moss J, Vaughan M.

J Biol Chem. 2000 Feb 4;275(5):3221-30.

7.
8.

Structural elements of ADP-ribosylation factor 1 required for functional interaction with cytohesin-1.

Pacheco-Rodriguez G, Patton WA, Adamik R, Yoo HS, Lee FJ, Zhang GF, Moss J, Vaughan M.

J Biol Chem. 1999 Apr 30;274(18):12438-44.

9.

Effects of arfaptin 1 on guanine nucleotide-dependent activation of phospholipase D and cholera toxin by ADP-ribosylation factor.

Tsai SC, Adamik R, Hong JX, Moss J, Vaughan M, Kanoh H, Exton JH.

J Biol Chem. 1998 Aug 14;273(33):20697-701.

10.

Cytohesin-1, a cytosolic guanine nucleotide-exchange protein for ADP-ribosylation factor.

Meacci E, Tsai SC, Adamik R, Moss J, Vaughan M.

Proc Natl Acad Sci U S A. 1997 Mar 4;94(5):1745-8.

12.
13.
14.

Characterization of recombinant and endogenous ADP-ribosylation factors synthesized in Sf9 insect cells.

Kunz BC, Muczynski KA, Welsh CF, Stanley SJ, Tsai SC, Adamik R, Chang PP, Moss J, Vaughan M.

Biochemistry. 1993 Jul 6;32(26):6643-8.

PMID:
8392366
15.

Effects of brefeldin A and accessory proteins on association of ADP-ribosylation factors 1, 3, and 5 with Golgi.

Tsai SC, Adamik R, Haun RS, Moss J, Vaughan M.

J Biol Chem. 1993 May 25;268(15):10820-5.

16.

Effect of myristoylation on GTP-dependent binding of ADP-ribosylation factor to Golgi.

Haun RS, Tsai SC, Adamik R, Moss J, Vaughan M.

J Biol Chem. 1993 Apr 5;268(10):7064-8.

17.

Effects of temperature on ADP-ribosylation factor stimulation of cholera toxin activity.

Murayama T, Tsai SC, Adamik R, Moss J, Vaughan M.

Biochemistry. 1993 Jan 19;32(2):561-6.

PMID:
8422366
18.

Differential interaction of ADP-ribosylation factors 1, 3, and 5 with rat brain Golgi membranes.

Tsai SC, Adamik R, Haun RS, Moss J, Vaughan M.

Proc Natl Acad Sci U S A. 1992 Oct 1;89(19):9272-6.

19.
20.

Activation of Escherichia coli heat-labile enterotoxins by native and recombinant adenosine diphosphate-ribosylation factors, 20-kD guanine nucleotide-binding proteins.

Lee CM, Chang PP, Tsai SC, Adamik R, Price SR, Kunz BC, Moss J, Twiddy EM, Holmes RK.

J Clin Invest. 1991 May;87(5):1780-6.

21.
22.

Mechanism of cholera toxin activation by a guanine nucleotide-dependent 19 kDa protein.

Noda M, Tsai SC, Adamik R, Moss J, Vaughan M.

Biochim Biophys Acta. 1990 May 16;1034(2):195-9.

PMID:
2112955
23.
24.

Structural and functional characterization of ADP-ribosylation factors, 20 kDa guanine nucleotide-binding proteins that activate cholera toxin.

Moss J, Tsuchiya M, Tsai SC, Adamik R, Bobak DA, Price SR, Nightingale MS, Vaughan M.

Adv Second Messenger Phosphoprotein Res. 1990;24:83-8. Review. No abstract available.

PMID:
2119662
25.

Activation of immobilized, biotinylated choleragen AI protein by a 19-kilodalton guanine nucleotide-binding protein.

Noda M, Tsai SC, Adamik R, Bobak DA, Moss J, Vaughan M.

Biochemistry. 1989 Sep 19;28(19):7936-40.

PMID:
2514798
26.

Microinjection of a 19-kDa guanine nucleotide-binding protein inhibits maturation of Xenopus oocytes.

Bahnson TD, Tsai SC, Adamik R, Moss J, Vaughan M.

J Biol Chem. 1989 Sep 5;264(25):14824-8.

27.

Expression of Go alpha mRNA and protein in bovine tissues.

Price SR, Tsai SC, Adamik R, Angus CW, Serventi IM, Tsuchiya M, Moss J, Vaughan M.

Biochemistry. 1989 May 2;28(9):3803-7.

PMID:
2502171
28.

Participation of a guanine nucleotide-binding protein cascade in cholera toxin activation of adenylate cyclase.

Vaughan M, Tsai SC, Noda M, Adamik R, Moss J.

J Mol Cell Cardiol. 1989 Feb;21 Suppl 1:97-102.

PMID:
2499682
29.

Isolation and immunological properties of adenosine kinase.

Noda M, Kunz BC, Tsai SC, Adamik R, Murtagh JJ, Chen HC, Halpern JL, Moss J.

Prep Biochem. 1989;19(4):351-61.

PMID:
2560184
30.

Effects of nitroprusside and nitroglycerin on cGMP content and PGI2 formation in aorta and vena cava.

Tsai SC, Adamik R, Manganiello VC, Moss J.

Biochem Pharmacol. 1989 Jan 1;38(1):61-5.

PMID:
2535935
31.

Mechanism of enhanced sensitivity to bradykinin in pertussis toxin-treated fibroblasts: toxin increases bradykinin-stimulated prostaglandin formation.

Moss J, Hom BE, Hewlett EL, Tsai SC, Adamik R, Halpern JL, Price SR, Manganiello VC.

Mol Pharmacol. 1988 Sep;34(3):279-85.

PMID:
2843748
32.

Guanine nucleotide-binding proteins that enhance choleragen ADP-ribosyltransferase activity: nucleotide and deduced amino acid sequence of an ADP-ribosylation factor cDNA.

Price SR, Nightingale M, Tsai SC, Williamson KC, Adamik R, Chen HC, Moss J, Vaughan M.

Proc Natl Acad Sci U S A. 1988 Aug;85(15):5488-91.

33.

Purification and characterization of ADP-ribosylarginine hydrolase from turkey erythrocytes.

Moss J, Tsai SC, Adamik R, Chen HC, Stanley SJ.

Biochemistry. 1988 Jul 26;27(15):5819-23.

PMID:
3179279
34.

Separation of the 24 kDa substrate for botulinum C3 ADP-ribosyltransferase and the cholera toxin ADP-ribosylation factor.

Tsai SC, Adamik R, Moss J, Aktories K.

Biochem Biophys Res Commun. 1988 May 16;152(3):957-61.

PMID:
3132159
35.

Stimulation of choleragen enzymatic activities by GTP and two soluble proteins purified from bovine brain.

Tsai SC, Noda M, Adamik R, Chang PP, Chen HC, Moss J, Vaughan M.

J Biol Chem. 1988 Feb 5;263(4):1768-72.

36.

Enhancement of choleragen ADP-ribosyltransferase activities by guanyl nucleotides and a 19-kDa membrane protein.

Tsai SC, Noda M, Adamik R, Moss J, Vaughan M.

Proc Natl Acad Sci U S A. 1987 Aug;84(15):5139-42.

38.
39.

Effects of nitroprusside on the bradykinin responsiveness of human fibroblasts.

Tsai SC, Adamik R, Hom BE, Manganiello VC, Moss J.

Mol Pharmacol. 1986 Sep;30(3):274-8.

PMID:
3018483
40.

Identification of the probable site of choleragen-catalyzed ADP-ribosylation in a Go alpha-like protein based on cDNA sequence.

Angus CW, Van Meurs KP, Tsai SC, Adamik R, Miedel MC, Pan YC, Kung HF, Moss J, Vaughan M.

Proc Natl Acad Sci U S A. 1986 Aug;83(16):5813-6.

41.

Structural and functional characterization of guanyl nucleotide-binding proteins using monoclonal antibodies to the alpha-subunit of transducin.

Halpern JL, Tsai SC, Adamik R, Kanaho Y, Bekesi E, Kung HF, Moss J, Vaughan M.

Mol Pharmacol. 1986 May;29(5):515-9.

PMID:
2422538
42.
43.

Effects of phospholipids and ADP-ribosylation on GTP hydrolysis by Escherichia coli-synthesized Ha-ras-encoded p21.

Tsai SC, Adamik R, Moss J, Vaughan M, Manne V, Kung HF.

Proc Natl Acad Sci U S A. 1985 Dec;82(24):8310-4.

44.

Pertussis toxin-catalyzed ADP-ribosylation of adenylate cyclase. Effects of guanyl nucleotides and rhodopsin.

Moss J, Tsai SC, Bruni P, Adamik R, Kanaho Y, Hewlett EL, Vaughan M.

Dev Biol Stand. 1985;61:43-9.

PMID:
3938969
45.
46.

Rhodopsin-enhanced GTPase activity of the inhibitory GTP-binding protein of adenylate cyclase.

Kanaho Y, Tsai SC, Adamik R, Hewlett EL, Moss J, Vaughan M.

J Biol Chem. 1984 Jun 25;259(12):7378-81.

47.

Regulation of activity of purified guanylate cyclase from liver that is unresponsive to nitric oxide.

Tsai SC, Adamik R, Manganiello VC, Vaughan M.

Biochem J. 1983 Dec 1;215(3):447-55.

48.

Reversible inactivation of soluble liver guanylate cyclase by disulfides.

Tsai SC, Adamik R, Manganiello VC, Vaughan M.

Biochem Biophys Res Commun. 1981 May 29;100(2):637-43. No abstract available.

PMID:
6115634
49.

Products of reaction catalyzed by purified rat liver guanylate cyclase determined by 31p NMR spectroscopy.

Tsai SC, Shindo H, Manganiello VC, Adamik R, Vaughan M.

Proc Natl Acad Sci U S A. 1980 Oct;77(10):5734-7.

50.

Differences in requirements and actions of various histamine-releasing agents.

Baxter JH, Adamik R.

Biochem Pharmacol. 1978 Feb 15;27(4):497-503. No abstract available.

PMID:
75731

Supplemental Content

Loading ...
Support Center